Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy

References

• Adkins Y, Kelley DS. (2010). Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 21:781–92.
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WC. (2012). The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1–16.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Sadeghi F, et al. (2015). Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. Int J Pharm 479:241–51.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Rezvani R, Farzad SA, et al. (2017). Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int J Pharm 532:581–94.
   PubMed Web of Science ®Google Scholar
• Assaraf YG, Leamon CP, Reddy JA. (2014). The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat 17:89–95.
   PubMed Web of Science ®Google Scholar
• Cao H, Dan Z, He X, et al. (2016). Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano 10:7738–48.
   PubMed Web of Science ®Google Scholar
• Cao X, Tan T, Zhu D, et al. (2020). Paclitaxel-loaded macrophage membrane camouflaged albumin nanoparticles for targeted cancer therapy. Int J Nanomedicine 15:1915–28.
   PubMed Web of Science ®Google Scholar
• Cardoso F, Kyriakides S, Ohno S, et al. (2019). Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30:1194–220.
   PubMed Web of Science ®Google Scholar
• Chen Y, Bathula SR, Yang Q, et al. (2010). Targeted nanoparticles deliver siRNA to melanoma. J Invest Dermatol 130:2790–8.
   PubMed Web of Science ®Google Scholar
• Dehaini D, Wei X, Fang RH, et al. (2017). Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater 29:1606209.
   Web of Science ®Google Scholar
• Fabian CJ, Kimler BF, Hursting SD. (2015). Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Res 17:62.
   PubMed Web of Science ®Google Scholar
• Fasehee H, Dinarvand R, Ghavamzadeh A, et al. (2016). Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations. J Nanobiotechnol 14:32.
   PubMed Web of Science ®Google Scholar
• Franco MS, Roque MC, de Barros ALB, et al. (2019). Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model. Biomed Pharmacother 109:1728–39.
   PubMed Web of Science ®Google Scholar
• Gawde KA, Sau S, Tatiparti K, et al. (2018). Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers. Colloids Surf B Biointerfaces 167:8–19.
   PubMed Web of Science ®Google Scholar
• Gohler S, Da Silva Filho MI, Johansson R, et al. (2017). Functional germline variants in driver genes of breast cancer. Cancer Causes Control 28:259–71.
   PubMed Web of Science ®Google Scholar
• Hazeldine J, Harris P, Chapple IL, et al. (2014). Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals. Aging Cell 13:690–8.
   PubMed Web of Science ®Google Scholar
• Hu J, Yuan XW, Wang F, et al. (2021). The progress and perspective of strategies to improve tumor penetration of nanomedicines. Chin Chem Lett 32:1341–7.
   Web of Science ®Google Scholar
• Jin X, Zhang J, Jin X, et al. (2020). Folate receptor targeting and cathepsin B-sensitive drug delivery system for selective cancer cell death and imaging. ACS Med Chem Lett 11:1514–20.
   PubMed Web of Science ®Google Scholar
• Khalifa AM, Elsheikh MA, Khalifa AM, et al. (2019). Current strategies for different paclitaxel-loaded nano-delivery systems towards therapeutic applications for ovarian carcinoma: a review article. J Control Release 311–312:125–37.
   PubMed Web of Science ®Google Scholar
• Kumari P, Ghosh B, Biswas S. (2016). Nanocarriers for cancer-targeted drug delivery. J Drug Target 24:179–91.
   PubMed Web of Science ®Google Scholar
• Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, et al. (2008). Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol 26:442–9.
   PubMed Web of Science ®Google Scholar
• Ma Y, Wang Y, Song B. (2019). Griffipavixanthone induces apoptosis of human breast cancer MCF-7 cells in vitro. Breast Cancer 26:190–7.
   PubMed Web of Science ®Google Scholar
• Maheo K, Vibet S, Steghens JP, et al. (2005). Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation. Free Radic Biol Med 39:742–51.
   PubMed Web of Science ®Google Scholar
• Mohammad RM, Muqbil I, Lowe L, et al. (2015). Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol 35:S78–S103.
   PubMed Web of Science ®Google Scholar
• Monteiro CAP, Oliveira A, Silva RC, et al. (2020). Evaluating internalization and recycling of folate receptors in breast cancer cells using quantum dots. J Photochem Photobiol B 209:111918.
   PubMed Web of Science ®Google Scholar
• Mouradian M, Kikawa KD, Dranka BP, et al. (2015). Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function. Mol Carcinog 54:810–20.
   PubMed Web of Science ®Google Scholar
• Muhamad N, Plengsuriyakarn T, Na-Bangchang K. (2018). Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int J Nanomedicine 13:3921–35.
   PubMed Web of Science ®Google Scholar
• Mussi SV, Sawant R, Perche F, et al. (2014). Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells. Pharm Res 31:1882–92.
   PubMed Web of Science ®Google Scholar
• Mussi SV, Silva RC, Oliveira MC, et al. (2013). New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles. Eur J Pharm Sci 48:282–90.
   PubMed Web of Science ®Google Scholar
• Niu F, Yan J, Ma B, et al. (2018). Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy. Biomaterials 167:132–42.
   PubMed Web of Science ®Google Scholar
• Oroojalian F, Babaei M, Taghdisi SM, et al. (2018). Encapsulation of thermo-responsive gel in pH-sensitive polymersomes as dual-responsive smart carriers for controlled release of doxorubicin. J Control Release 288:45–61.
   PubMed Web of Science ®Google Scholar
• Park J, Choi Y, Chang H, et al. (2019). Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment. Theranostics 9:8073–90.
   PubMed Web of Science ®Google Scholar
• Ponde NF, Zardavas D, Piccart M. (2019). Progress in adjuvant systemic therapy for breast cancer. Nat Rev Clin Oncol 16:27–44.
   PubMed Web of Science ®Google Scholar
• Qin T, Xu X, Zhang Z, et al. (2020). Paclitaxel/sunitinib-loaded micelles promote an antitumor response in vitro through synergistic immunogenic cell death for triple-negative breast cancer. Nanotechnology 31:365101.
   PubMed Web of Science ®Google Scholar
• Ren X, Wang N, Zhou Y, et al. (2021). An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway. Acta Biomater 124:179–90.
   PubMed Web of Science ®Google Scholar
• Rescigno T, Capasso A, Tecce MF. (2016). Effect of docosahexaenoic acid on cell cycle pathways in breast cell lines with different transformation degree. J Cell Physiol 231:1226–36.
   PubMed Web of Science ®Google Scholar
• Serini S, Ottes Vasconcelos R, Nascimento Gomes R, et al. (2017). Protective effects of omega-3 PUFA in anthracycline-induced cardiotoxicity: a critical review. Int J Mol Sci 18:2689.
   PubMed Web of Science ®Google Scholar
• Shen M, Huang Y, Han L, et al. (2012). Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. J Control Release 161:884–92.
   PubMed Web of Science ®Google Scholar
• Siddiqui RA, Harvey KA, Xu Z, et al. (2011). Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. Biofactors 37:399–412.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. (2020). Cancer statistics, 2020. CA Cancer J Clin 70:7–30.
   PubMed Web of Science ®Google Scholar
• Sun H, Su J, Meng Q, et al. (2016). Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors. Adv Mater 28:9581–8.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–49.
   PubMed Web of Science ®Google Scholar
• Tang H, Chen J, Wang L, et al. (2020). Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer. Int J Pharm 573:118806.
   PubMed Web of Science ®Google Scholar
• Untch M, Jackisch C, Schneeweiss A, et al. (2016). Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial. Lancet Oncol 17:345–56.
   PubMed Web of Science ®Google Scholar
• Wang J, Li D, Cang H, et al. (2019). Crosstalk between cancer and immune cells: role of tumor-associated macrophages in the tumor microenvironment. Cancer Med 8:4709–21.
   PubMed Web of Science ®Google Scholar
• Wang TM, Chen CJ, Lee TS, et al. (2011). Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells. J Nutr Biochem 22:187–94.
   PubMed Web of Science ®Google Scholar
• Wong RS. (2011). Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30:87.
   PubMed Web of Science ®Google Scholar
• Wu Q, Yang Z, Nie Y, et al. (2014). Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett 347:159–66.
   PubMed Web of Science ®Google Scholar
• Yao Q, Gutierrez DC, Hoang NH, et al. (2017). Efficient codelivery of paclitaxel and curcumin by novel bottlebrush copolymer-based micelles. Mol Pharm 14:2378–89.
   PubMed Web of Science ®Google Scholar
• Yu W, Hu C, Gao H. (2021). Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages. Adv Drug Deliv Rev 178:113909.
   PubMed Web of Science ®Google Scholar
• Yuan H, Miao J, Du YZ, et al. (2008). Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm 348:137–45.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun X, Li J, et al. (2011). Lipid nanoemulsions loaded with doxorubicin–oleic acid ionic complex: characterization, in vitro and in vivo studies. Pharmazie 66:496–505.
   PubMed Web of Science ®Google Scholar
• Zheng X, Xie JZ, Zhang X, et al. (2021). An overview of polymeric nanomicelles in clinical trials and on the market. Chin Chem Lett 32:243–57.
   Web of Science ®Google Scholar